MBII - Marrone Bio Innovations - Stock Forecast

Basic Materials - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Marrone Bio Innovations's activity chart (see below) currently has 19 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.67% with an average time for these price targets to be met of 64.4 days.

Most recent stock forecast was given by GERRY SWEENEY from ROTH on 14-Apr-2022.

Best performing analysts who are covering MBII - Marrone Bio Innovations:

Laurence Alexander Bobby Burleson Gerry Sweeney Paul Massoud Amit Dayal Ben Kallo

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 11-Mar-2016

$0.9

$0.1 (12.50%)

$1.5

Buy Since 28-Jul-2020

$2

$1.2 (150.00%)

$1.8

Buy Since 27-Aug-2013

$10

$9.2 (1150.00%)

$19

Show more analysts

Please expand the browser size to see the chart

What is MBII (Marrone Bio Innovations) average time for price targets to be met?

On average it took 64.4 days on average for the stock forecasts to be realized with a an average price target met ratio 32.67

Which analyst has the current highest performing score on MBII (Marrone Bio Innovations) with a proven track record?

LAURENCE ALEXANDER

Which analyst has the most public recommendations on MBII (Marrone Bio Innovations)?

Laurence Alexander works at JEFFERIES and has 7 price targets and 5 ratings on MBII

Which analyst is the currently most bullish on MBII (Marrone Bio Innovations)?

Ben Kallo with highest potential upside - $11.2

Which analyst is the currently most reserved on MBII (Marrone Bio Innovations)?

Laurence Alexander with lowest potential downside - $0.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?